Biolife Solutions Inc (BLFS) - Comprehensive Stock Analysis & Investment Research
Deep dive into Biolife Solutions Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Biolife Solutions Inc Investment Summary
When evaluating whether Biolife Solutions Inc (BLFS) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Biolife Solutions Inc (BLFS) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry. The company employs approximately 168 people. With a market capitalization of $875 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Biolife Solutions Inc's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Biolife Solutions Inc along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Biolife Solutions Inc is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Biolife Solutions Inc (Stock Symbol: BLFS) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Electromedical & Electrotherapeutic Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Biolife Solutions Inc's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Biolife Solutions Inc...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Biolife Solutions Inc...
Revenue & Growth Analysis
Biolife Solutions Inc generates annual revenues of $11 million , representing an emerging company in its growth phase.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Biolife Solutions Inc...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Biolife Solutions Inc...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Biolife Solutions Inc...
Strategic Market Position
Biolife Solutions Inc strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Biolife Solutions Inc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-22 million , with year-over-year cash flow growth of 447.8%. Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Asset Utilization Efficiency
Asset turnover ratio of 0.35x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 3.39 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.